BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1812 related articles for article (PubMed ID: 8837543)

  • 1. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 4. Calcium nutrition and osteoporosis.
    Murray TM
    CMAJ; 1996 Oct; 155(7):935-9. PubMed ID: 8837543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.
    Jones G; Hogan DB; Yendt E; Hanley DA
    CMAJ; 1996 Oct; 155(7):955-61. PubMed ID: 8837546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada.
    CMAJ; 1996 Oct; 155(8):1113-33. PubMed ID: 8873639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG
    CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 6. Use of bisphosphonates in the treatment of osteoporosis.
    Hodsman A; Adachi J; Olszynski W
    CMAJ; 1996 Oct; 155(7):945-8. PubMed ID: 8837544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis.
    Siminoski K; Josse RG
    CMAJ; 1996 Oct; 155(7):962-5. PubMed ID: 8837547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 7. Fluoride therapy for osteoporosis.
    Murray TM; Ste-Marie LG
    CMAJ; 1996 Oct; 155(7):949-54. PubMed ID: 8837545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoporosis: new hope for the future.
    Masi L; Bilezikian JP
    Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of calcium in peri- and postmenopausal women: 2006 position statement of the North American Menopause Society.
    North American Menopause Society
    Menopause; 2006; 13(6):862-77; quiz 878-80. PubMed ID: 17106282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and management of primary osteoporosis.
    Bauwens SF; Drinka PJ; Boh LE
    Clin Pharm; 1986 Aug; 5(8):639-59. PubMed ID: 3527528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of calcium, vitamin D and vitamin K for osteoporosis prevention and treatment.
    Lanham-New SA
    Proc Nutr Soc; 2008 May; 67(2):163-76. PubMed ID: 18412990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 5. Physical activity as therapy for osteoporosis.
    Prior JC; Barr SI; Chow R; Faulkner RA
    CMAJ; 1996 Oct; 155(7):940-4. PubMed ID: 8925493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2006; 13(3):340-67; quiz 368-9. PubMed ID: 16735931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of vitamin D, its metabolites, and analogs in the management of osteoporosis.
    Bikle DD
    Rheum Dis Clin North Am; 1994 Aug; 20(3):759-75. PubMed ID: 7984788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vitamin D endocrine system, calcium metabolism, and osteoporosis.
    Slovik DM
    Spec Top Endocrinol Metab; 1983; 5():83-148. PubMed ID: 6367121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing fracture risk with calcium and vitamin D.
    Lips P; Bouillon R; van Schoor NM; Vanderschueren D; Verschueren S; Kuchuk N; Milisen K; Boonen S
    Clin Endocrinol (Oxf); 2010 Sep; 73(3):277-85. PubMed ID: 20796001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal calcium intake.
    NIH Consens Statement; 1994 Jun 6-8; 12(4):1-31. PubMed ID: 7599655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major scientific advances with dairy foods in nutrition and health.
    Huth PJ; DiRienzo DB; Miller GD
    J Dairy Sci; 2006 Apr; 89(4):1207-21. PubMed ID: 16537954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 91.